Vascular dormancy is the result of a balance between pro-angiogenic factors (VEGF and PDGF) and anti-angiogenic factors (thrombospondin, endostatin, and vasopressors) (Naumov et al., 2006), leading to tumor growth inhibition. This evidence concerns the gene VEGFA and neoplasm.